UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population

Journal of vascular surgery, 2014-09, Vol.60 (3), p.686-695.e2

2014

Volltextzugriff (PDF)

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

The New England journal of medicine, 2017-01, Vol.376 (1), p.32-40

2017

Volltextzugriff (PDF)

Rivaroxaban in Peripheral Artery Disease after Revascularization

The New England journal of medicine, 2020-05, Vol.382 (21), p.1994-2004

2020

Volltextzugriff (PDF)

An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee

Catheterization and cardiovascular interventions, 2015-10, Vol.86 (4), p.611-625

2015

Volltextzugriff (PDF)

Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease

Circulation (New York, N.Y.), 2017-01, Vol.135 (3), p.241-250

2017

Volltextzugriff (PDF)

Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program

Diabetologia, 2019-06, Vol.62 (6), p.926-938

2019

Volltextzugriff (PDF)

The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications

Thrombosis and haemostasis, 2016-06, Vol.115 (6), p.1240-1248

2016

Volltextzugriff (PDF)

Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study

The American heart journal, 2021-05, Vol.235, p.12-23

2021

Volltextzugriff (PDF)

Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients

Journal of the American College of Cardiology, 2020-06, Vol.75 (25), p.3140-3147

2020

Volltextzugriff (PDF)

Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial

Circulation (New York, N.Y.), 2021-10, Vol.144 (14), p.1104-1116

2021

Volltextzugriff (PDF)

Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial

Journal of the American College of Cardiology, 2018-12, Vol.72 (25), p.3274-3284

2018

Volltextzugriff (PDF)

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)

Journal of vascular surgery, 2008-02, Vol.47 (2), p.330-336.e2

2008

Volltextzugriff (PDF)

Design and Rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) Trial

The American heart journal, 2016-05, Vol.175, p.86-93

2016

Volltextzugriff (PDF)

Behavior-Change Intervention Targeting Physical Function, Walking, and Disability After Dysvascular Amputation: A Randomized Controlled Pilot Trial

Archives of physical medicine and rehabilitation, 2018-11, Vol.99 (11), p.2160-2167

2018

Volltextzugriff (PDF)

A High Ankle-Brachial Index Is Associated With Increased Cardiovascular Disease Morbidity and Lower Quality of Life

Journal of the American College of Cardiology, 2008-04, Vol.51 (13), p.1292-1298

2008

Volltextzugriff (PDF)

Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD

Journal of the American College of Cardiology, 2021-11, Vol.78 (18), p.1768

2021

Volltextzugriff (PDF)

Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial

European journal of preventive cardiology, 2015-06, Vol.22 (6), p.734-742

2015

Volltextzugriff (PDF)

CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial

The American heart journal, 2020-11, Vol.229, p.118-120

2020

Volltextzugriff (PDF)

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

The New England journal of medicine, 2018-09, Vol.379 (12), p.1118-1127

2018

Volltextzugriff (PDF)

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

Circulation (New York, N.Y.), 2003-09, Vol.108 (12), p.1481-1486

2003

Volltextzugriff (PDF)

Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization

Annals of vascular surgery, 2021-08, Vol.75, p.217-226

2021

Volltextzugriff (PDF)

Association between physical activity and peripheral artery disease and carotid artery stenosis in a self-referred population of 3 million adults

Arteriosclerosis, thrombosis, and vascular biology, 2015-01, Vol.35 (1), p.206-212

2015

Volltextzugriff (PDF)

Should an Alternate ABI Definition Be Adopted to Evaluate Risk?

Journal of the American College of Cardiology, 2013-08, Vol.62 (6), p.560-561

Hiatt, William R., MD

2013

Volltextzugriff (PDF)

Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation

The American heart journal, 2015-09, Vol.170 (3), p.490-497.e1

2015

Volltextzugriff (PDF)

Relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease

Journal of applied physiology (1985), 2011-07, Vol.111 (1), p.81-86

2011

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Aktive Filter

ThemaBlood And Lymphatic Vessels

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(132)

Publikationsform

Artikel
(162)

Sprache

Englisch
(162)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

Rivaroxaban in Peripheral Artery Disease after Revascularization

An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II): The TASC steering committee

Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease

Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program

The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications

Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study

Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients

Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial

Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects)

Design and Rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) Trial

Behavior-Change Intervention Targeting Physical Function, Walking, and Disability After Dysvascular Amputation: A Randomized Controlled Pilot Trial

A High Ankle-Brachial Index Is Associated With Increased Cardiovascular Disease Morbidity and Lower Quality of Life

Safety and Effectiveness of Paclitaxel Drug-Coated Devices in Peripheral Artery Revascularization: Insights From VOYAGER PAD

Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial

CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization

Association between physical activity and peripheral artery disease and carotid artery stenosis in a self-referred population of 3 million adults

Should an Alternate ABI Definition Be Adopted to Evaluate Risk?

Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation

Relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease

Aktive Filter

Suchergebnisse filtern